Financial Toxicity of Cancer Care: It's Time to Intervene
Evidence suggests that a considerably large proportion of cancer patients are affected by treatment-related financial harm. As medical debt grows for some with cancer, the downstream effects can be catastrophic, with a recent study suggesting a link between extreme financial distress and worse morta...
Gespeichert in:
| Veröffentlicht in: | JNCI : Journal of the National Cancer Institute Jg. 108; H. 5 |
|---|---|
| 1. Verfasser: | |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.05.2016
|
| Schlagworte: | |
| ISSN: | 1460-2105, 1460-2105 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Evidence suggests that a considerably large proportion of cancer patients are affected by treatment-related financial harm. As medical debt grows for some with cancer, the downstream effects can be catastrophic, with a recent study suggesting a link between extreme financial distress and worse mortality. At least three factors might explain the relationship between extreme financial distress and greater risk of mortality: 1) overall poorer well-being, 2) impaired health-related quality of life, and 3) sub-par quality of care. While research has described the financial harm associated with cancer treatment, little has been done to effectively intervene on the problem. Long-term solutions must focus on policy changes to reduce unsustainable drug prices and promote innovative insurance models. In the mean time, patients continue to struggle with high out-of-pocket costs. For more immediate solutions, we should look to the oncologist and patient. Oncologists should focus on the value of care delivered, encourage patient engagement on the topic of costs, and be better educated on financial resources available to patients. For their part, patients need improved cost-related health literacy so they are aware of potential costs and resources, and research should focus on how patients define high-value care. With a growing list of financial side effects induced by cancer treatment, the time has come to intervene on the "financial toxicity" of cancer care. |
|---|---|
| AbstractList | Evidence suggests that a considerably large proportion of cancer patients are affected by treatment-related financial harm. As medical debt grows for some with cancer, the downstream effects can be catastrophic, with a recent study suggesting a link between extreme financial distress and worse mortality. At least three factors might explain the relationship between extreme financial distress and greater risk of mortality: 1) overall poorer well-being, 2) impaired health-related quality of life, and 3) sub-par quality of care. While research has described the financial harm associated with cancer treatment, little has been done to effectively intervene on the problem. Long-term solutions must focus on policy changes to reduce unsustainable drug prices and promote innovative insurance models. In the mean time, patients continue to struggle with high out-of-pocket costs. For more immediate solutions, we should look to the oncologist and patient. Oncologists should focus on the value of care delivered, encourage patient engagement on the topic of costs, and be better educated on financial resources available to patients. For their part, patients need improved cost-related health literacy so they are aware of potential costs and resources, and research should focus on how patients define high-value care. With a growing list of financial side effects induced by cancer treatment, the time has come to intervene on the "financial toxicity" of cancer care.Evidence suggests that a considerably large proportion of cancer patients are affected by treatment-related financial harm. As medical debt grows for some with cancer, the downstream effects can be catastrophic, with a recent study suggesting a link between extreme financial distress and worse mortality. At least three factors might explain the relationship between extreme financial distress and greater risk of mortality: 1) overall poorer well-being, 2) impaired health-related quality of life, and 3) sub-par quality of care. While research has described the financial harm associated with cancer treatment, little has been done to effectively intervene on the problem. Long-term solutions must focus on policy changes to reduce unsustainable drug prices and promote innovative insurance models. In the mean time, patients continue to struggle with high out-of-pocket costs. For more immediate solutions, we should look to the oncologist and patient. Oncologists should focus on the value of care delivered, encourage patient engagement on the topic of costs, and be better educated on financial resources available to patients. For their part, patients need improved cost-related health literacy so they are aware of potential costs and resources, and research should focus on how patients define high-value care. With a growing list of financial side effects induced by cancer treatment, the time has come to intervene on the "financial toxicity" of cancer care. Evidence suggests that a considerably large proportion of cancer patients are affected by treatment-related financial harm. As medical debt grows for some with cancer, the downstream effects can be catastrophic, with a recent study suggesting a link between extreme financial distress and worse mortality. At least three factors might explain the relationship between extreme financial distress and greater risk of mortality: 1) overall poorer well-being, 2) impaired health-related quality of life, and 3) sub-par quality of care. While research has described the financial harm associated with cancer treatment, little has been done to effectively intervene on the problem. Long-term solutions must focus on policy changes to reduce unsustainable drug prices and promote innovative insurance models. In the mean time, patients continue to struggle with high out-of-pocket costs. For more immediate solutions, we should look to the oncologist and patient. Oncologists should focus on the value of care delivered, encourage patient engagement on the topic of costs, and be better educated on financial resources available to patients. For their part, patients need improved cost-related health literacy so they are aware of potential costs and resources, and research should focus on how patients define high-value care. With a growing list of financial side effects induced by cancer treatment, the time has come to intervene on the "financial toxicity" of cancer care. |
| Author | Zafar, S Yousuf |
| Author_xml | – sequence: 1 givenname: S Yousuf surname: Zafar fullname: Zafar, S Yousuf email: yousuf.zafar@duke.edu organization: Duke Cancer Institute; Sanford School of Public Policy, Duke University, Durham, NC. yousuf.zafar@duke.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26657334$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNT01LxDAUDLLifujJu-Sml7pJmjQ-b1JcLSx4qeeSbV4gS5uuTbu4_96CKziXGYZhmFmSWegCEnLL2SNnkK73ofZruz-mml2QBZcZSwRnavZPz8kyxj2bAEJekbnIMqXTVC4IbHwwU4FpaNl9-9oPJ9o5mk8e9hP1-EyL4T7S0rdIh44WYcD-iAGvyaUzTcSbM6_I5-a1zN-T7cdbkb9skzoV2ZBoxRxYxlBITKVVWtgakDm-M_XTNMcxpbjUgIYDd0aA1DazmTLOgpKcixV5-O099N3XiHGoWh9rbBoTsBtjxbUEAAVaTtG7c3TctWirQ-9b05-qv7viB5FjVoQ |
| CitedBy_id | crossref_primary_10_1002_cam4_6905 crossref_primary_10_1016_j_jval_2018_09_2844 crossref_primary_10_1200_JCO_23_01149 crossref_primary_10_1001_jamainternmed_2022_3687 crossref_primary_10_1891_JNM_D_20_00140 crossref_primary_10_1186_s12905_025_03826_9 crossref_primary_10_1007_s00520_021_06036_9 crossref_primary_10_1007_s11764_024_01710_3 crossref_primary_10_1002_cam4_4164 crossref_primary_10_1002_cncr_33468 crossref_primary_10_1002_cncr_32012 crossref_primary_10_1007_s40944_024_00949_z crossref_primary_10_1080_14737167_2023_2263167 crossref_primary_10_4251_wjgo_v14_i1_216 crossref_primary_10_1016_j_ijrobp_2020_09_045 crossref_primary_10_1111_hex_13642 crossref_primary_10_1186_s13561_019_0253_7 crossref_primary_10_1097_DCR_0000000000000922 crossref_primary_10_1177_1078155217692400 crossref_primary_10_1002_cam4_6911 crossref_primary_10_1007_s10730_022_09478_8 crossref_primary_10_1007_s00520_025_09676_3 crossref_primary_10_1038_nrd_2016_233 crossref_primary_10_1200_JCO_2017_73_7817 crossref_primary_10_1188_19_CJON_S2_31_35 crossref_primary_10_3390_cancers16101904 crossref_primary_10_1002_phar_2013 crossref_primary_10_1097_MAT_0000000000000847 crossref_primary_10_1016_j_semradonc_2022_11_002 crossref_primary_10_1188_19_CJON_S2_3_4 crossref_primary_10_1186_s12913_024_11077_x crossref_primary_10_1016_j_semradonc_2024_07_001 crossref_primary_10_1007_s00520_022_07264_3 crossref_primary_10_1007_s00520_021_06288_5 crossref_primary_10_1200_JGO_19_00109 crossref_primary_10_7759_cureus_61625 crossref_primary_10_1371_journal_pone_0300852 crossref_primary_10_1097_BOT_0000000000002520 crossref_primary_10_1007_s00520_024_08451_0 crossref_primary_10_3389_fpubh_2025_1391744 crossref_primary_10_1002_cam4_5713 crossref_primary_10_1186_s12913_024_10916_1 crossref_primary_10_2147_PPA_S271620 crossref_primary_10_1007_s10552_021_01498_y crossref_primary_10_1155_ecc_6591289 crossref_primary_10_1200_JCO_24_00962 crossref_primary_10_1007_s11764_017_0669_1 crossref_primary_10_1513_AnnalsATS_202408_865OC crossref_primary_10_3390_ijerph17082831 crossref_primary_10_1007_s00520_023_08019_4 crossref_primary_10_2478_raon_2025_0002 crossref_primary_10_3389_fonc_2022_1011052 crossref_primary_10_37551_S2254_28842024003 crossref_primary_10_1002_pon_5361 crossref_primary_10_7326_M20_1392 crossref_primary_10_1188_19_CJON_S2_14_18 crossref_primary_10_3390_healthcare8040366 crossref_primary_10_1007_s11764_024_01668_2 crossref_primary_10_1111_jrh_12637 crossref_primary_10_1002_cnr2_1880 crossref_primary_10_1080_13548506_2019_1619787 crossref_primary_10_1186_s12913_022_08201_0 crossref_primary_10_1080_07347332_2021_1915441 crossref_primary_10_1016_j_jss_2022_11_074 crossref_primary_10_1002_pon_70034 crossref_primary_10_1188_18_CJON_286_294 crossref_primary_10_1016_j_bioorg_2023_106902 crossref_primary_10_1200_JCO_2017_75_2501 crossref_primary_10_1007_s11764_020_00916_5 crossref_primary_10_1016_j_jhqr_2020_07_004 crossref_primary_10_1200_EDBK_238879 crossref_primary_10_1093_hsw_hlac004 crossref_primary_10_3389_fpubh_2022_842837 crossref_primary_10_1093_jncics_pkae067 crossref_primary_10_1097_MLR_0000000000001910 crossref_primary_10_1097_01_JMQ_0000749852_10699_bc crossref_primary_10_1007_s40273_018_0656_z crossref_primary_10_1186_s12885_019_5613_5 crossref_primary_10_1007_s00520_025_09828_5 crossref_primary_10_1177_10781552221082214 crossref_primary_10_1007_s00520_022_06873_2 crossref_primary_10_7759_cureus_58643 crossref_primary_10_1093_jnci_djab049 crossref_primary_10_3390_jcm13175286 crossref_primary_10_1007_s12282_025_01764_w crossref_primary_10_5294_aqui_2024_24_1_6 crossref_primary_10_1093_jnci_djac135 crossref_primary_10_1002_cam4_7088 crossref_primary_10_1016_j_cgh_2020_06_049 crossref_primary_10_1016_j_urology_2025_03_028 crossref_primary_10_1089_pop_2017_0198 crossref_primary_10_2147_JHC_S523284 crossref_primary_10_1007_s00520_021_06113_z crossref_primary_10_1016_j_jpainsymman_2020_05_008 crossref_primary_10_1007_s11606_019_05002_w crossref_primary_10_1016_j_ijrobp_2022_03_009 crossref_primary_10_1016_j_jacr_2022_07_014 crossref_primary_10_2174_1874467214666211006123728 crossref_primary_10_1016_j_amepre_2018_07_021 crossref_primary_10_1177_15347354211040780 crossref_primary_10_1007_s00520_025_09271_6 crossref_primary_10_5435_JAAOS_D_18_00252 crossref_primary_10_1016_j_ssmqr_2023_100285 crossref_primary_10_1002_eahr_60016 crossref_primary_10_3389_fpubh_2023_1266533 crossref_primary_10_1089_jayao_2022_0011 crossref_primary_10_1136_ebnurs_2024_104003 crossref_primary_10_1007_s40259_019_00383_0 crossref_primary_10_1186_s13063_021_05369_4 crossref_primary_10_1002_jso_24331 crossref_primary_10_1186_s12885_025_14635_6 crossref_primary_10_1002_cam4_5244 crossref_primary_10_3390_cancers13174272 crossref_primary_10_1007_s00520_021_06086_z crossref_primary_10_1097_PRS_0000000000007703 crossref_primary_10_1097_PRS_0000000000007704 crossref_primary_10_1136_bmjopen_2023_082622 crossref_primary_10_1177_1558944719866889 crossref_primary_10_1089_jayao_2019_0120 crossref_primary_10_1007_s00520_025_09498_3 crossref_primary_10_1007_s00520_020_05719_z crossref_primary_10_1097_PRS_0000000000008113 crossref_primary_10_1186_s40545_017_0115_9 crossref_primary_10_1007_s00520_021_05984_6 crossref_primary_10_1007_s00520_020_05779_1 crossref_primary_10_1155_2023_6292479 crossref_primary_10_2196_43404 crossref_primary_10_1007_s11764_019_00764_y crossref_primary_10_1017_S1478951517000979 crossref_primary_10_1016_S0960_9776_19_31135_X crossref_primary_10_1007_s00520_019_05274_2 crossref_primary_10_1089_jayao_2022_0103 crossref_primary_10_1177_2284026520905239 crossref_primary_10_1007_s00520_022_07501_9 crossref_primary_10_1007_s00520_020_05468_z crossref_primary_10_1634_theoncologist_2019_0338 crossref_primary_10_1093_jnci_djab013 crossref_primary_10_1080_17474086_2019_1682545 crossref_primary_10_1007_s40271_016_0204_x crossref_primary_10_1016_j_ahj_2021_04_011 crossref_primary_10_1055_s_0042_1748798 crossref_primary_10_5334_aogh_2978 crossref_primary_10_2196_47255 crossref_primary_10_3390_cancers15061686 crossref_primary_10_1186_s12889_022_13980_6 crossref_primary_10_3389_fonc_2022_1004102 crossref_primary_10_1016_j_ccell_2021_04_002 crossref_primary_10_1002_cam4_2837 crossref_primary_10_3389_fpsyt_2025_1481752 crossref_primary_10_1177_2374373518808309 crossref_primary_10_1007_s00520_018_4418_4 crossref_primary_10_1093_qje_qjae045 crossref_primary_10_1097_JU_0000000000004188 crossref_primary_10_1188_20_CJON_209_213 crossref_primary_10_1097_PPO_0000000000000457 crossref_primary_10_2196_52841 crossref_primary_10_1097_SLA_0000000000003042 crossref_primary_10_1097_MPH_0000000000001297 crossref_primary_10_1634_theoncologist_2016_0174 crossref_primary_10_1007_s00520_023_07647_0 crossref_primary_10_1007_s10549_023_07160_2 crossref_primary_10_1097_PRS_0000000000009823 crossref_primary_10_1007_s40261_023_01251_0 crossref_primary_10_1007_s00520_021_06191_z crossref_primary_10_1002_cncr_34146 crossref_primary_10_1007_s00520_021_06420_5 crossref_primary_10_1111_ajag_12739 crossref_primary_10_1007_s10865_022_00349_8 crossref_primary_10_1002_cncr_34251 crossref_primary_10_1038_s41585_019_0258_3 crossref_primary_10_1007_s11764_023_01361_w crossref_primary_10_1007_s10552_024_01878_0 crossref_primary_10_1016_j_breast_2022_07_006 crossref_primary_10_1177_08258597241253933 crossref_primary_10_1188_17_CJON_762_764 crossref_primary_10_1177_10499091231187999 crossref_primary_10_1002_hed_26801 crossref_primary_10_1188_19_CJON_S2_27_30 crossref_primary_10_3389_fonc_2021_690454 crossref_primary_10_1097_MED_0000000000000826 crossref_primary_10_1111_ans_18820 crossref_primary_10_1177_10732748251339251 crossref_primary_10_3322_caac_21672 crossref_primary_10_1245_s10434_022_12570_5 crossref_primary_10_1007_s11764_019_00799_1 crossref_primary_10_1097_NCC_0000000000000972 crossref_primary_10_3390_healthcare11131876 crossref_primary_10_1136_bmjopen_2021_057215 crossref_primary_10_3390_jcm10020188 crossref_primary_10_1097_NCC_0000000000001393 crossref_primary_10_1002_cncr_32860 crossref_primary_10_1007_s11899_016_0333_2 crossref_primary_10_1210_jendso_bvad064 crossref_primary_10_1177_1352458520913977 crossref_primary_10_1007_s00520_023_08066_x crossref_primary_10_3390_cancers15235498 crossref_primary_10_1186_s13561_023_00463_6 crossref_primary_10_1007_s12312_022_01097_1 crossref_primary_10_1080_10437797_2016_1212751 crossref_primary_10_1182_bloodadvances_2019001317 crossref_primary_10_1186_s12913_016_1353_2 crossref_primary_10_1007_s00520_023_08172_w crossref_primary_10_1093_ajhp_zxz022 crossref_primary_10_1007_s00134_019_05781_0 crossref_primary_10_1080_07347332_2021_1937771 crossref_primary_10_1245_s10434_024_16013_1 crossref_primary_10_1158_1078_0432_CCR_17_3705 crossref_primary_10_1097_PRS_0000000000007798 crossref_primary_10_3390_cancers11050706 crossref_primary_10_1093_jncimonographs_lgad030 crossref_primary_10_3390_cancers13195015 crossref_primary_10_1007_s00520_019_05119_y crossref_primary_10_1200_OP_25_00218 crossref_primary_10_1007_s00520_021_06758_w crossref_primary_10_1002_cnr2_1381 crossref_primary_10_1002_onco_13544 crossref_primary_10_1007_s11864_019_0608_7 crossref_primary_10_1080_07347332_2022_2142877 crossref_primary_10_1188_22_CJON_165_175 crossref_primary_10_1007_s11764_025_01817_1 crossref_primary_10_1002_cncr_30940 crossref_primary_10_1080_07347332_2018_1523822 crossref_primary_10_3390_cancers15174315 crossref_primary_10_3390_cancers12113325 crossref_primary_10_1002_cncr_34626 crossref_primary_10_1007_s00520_021_06697_6 crossref_primary_10_1016_j_jcpo_2021_100305 crossref_primary_10_1080_14737167_2019_1680289 crossref_primary_10_1186_s13561_018_0196_4 crossref_primary_10_1200_JCO_18_00270 crossref_primary_10_1136_bmjqs_2024_017557 crossref_primary_10_2174_0929867330666230607104441 crossref_primary_10_1007_s00520_021_06762_0 crossref_primary_10_1016_j_jcpo_2025_100616 crossref_primary_10_1212_WNL_0000000000201627 crossref_primary_10_1016_j_clml_2020_12_018 crossref_primary_10_1186_s12913_024_11357_6 crossref_primary_10_1007_s00520_025_09252_9 crossref_primary_10_1097_NCC_0000000000001125 crossref_primary_10_1093_jnci_djw205 crossref_primary_10_2106_JBJS_24_00345 crossref_primary_10_1016_j_soncn_2019_06_003 crossref_primary_10_1245_s10434_022_12172_1 crossref_primary_10_1089_jayao_2022_0099 crossref_primary_10_1093_hsw_hlaf021 crossref_primary_10_3389_fpsyg_2023_1176843 crossref_primary_10_7554_eLife_92074_3 crossref_primary_10_1007_s00520_023_07849_6 crossref_primary_10_1002_cam4_6731 crossref_primary_10_1136_jech_2018_211160 crossref_primary_10_1007_s00520_023_08169_5 crossref_primary_10_7554_eLife_92074 crossref_primary_10_1007_s10549_023_07053_4 crossref_primary_10_4081_jphr_2021_2403 crossref_primary_10_1002_cam4_3461 crossref_primary_10_1093_jnci_djaf152 crossref_primary_10_1007_s00520_024_08983_5 crossref_primary_10_1002_cncr_34047 crossref_primary_10_1097_01_NURSE_0000577692_18934_ff crossref_primary_10_1007_s11764_023_01344_x crossref_primary_10_1097_LVT_0000000000000320 crossref_primary_10_1093_nop_npae098 crossref_primary_10_5435_JAAOS_D_23_01071 |
| ContentType | Journal Article |
| Copyright | The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. |
| Copyright_xml | – notice: The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1093/jnci/djv370 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1460-2105 |
| ExternalDocumentID | 26657334 |
| Genre | Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- -DD -E4 -~X .2P .55 .GJ .I3 .XZ .ZR 08P 0R~ 186 1TH 29L 2QL 2WC 354 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WD 70D 8WZ 96U A6W AABZA AACZT AAGKA AAHTB AAJKP AAJQQ AAKAS AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL ABCQX ABDFA ABEFU ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNGD ABNHQ ABNKS ABOCM ABPEJ ABPMR ABPPZ ABPTD ABQLI ABQNK ABSMQ ABVGC ABXVV ABZBJ ACBMB ACFRR ACGFO ACGFS ACGOD ACKOT ACNCT ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADXHL ADYVW ADZCM AEGPL AEHUL AEJOX AEKPW AEKSI AEMDU AEMQT AENZO AEPUE AETBJ AETEA AEWNT AFAZI AFCHL AFFNX AFFQV AFFZL AFIYH AFOFC AFRAH AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGNAY AGORE AGQPQ AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJBYB AJDVS AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BKOMP BTRTY BVRKM BZKNY C45 CAG CDBKE CGR COF CS3 CUY CVF CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS ECM EE~ EIF EIHJH EJD EMOBN ENERS F5P F8P F9B FA8 FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GOZPB GRPMH GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 J5H JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B LXL LXN LXY M-Z MBLQV MHKGH ML0 MVM N9A NGC NOMLY NOYVH NPM NTWIH NU- NVLIB O0~ OAUYM OAWHX OBFPC OBH OCB OCZFY ODMLO ODZKP OGEVE OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q.- Q1. Q5Y QBD R44 RD5 RNI RNS ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCURE TEORI TJX TMA TR2 TWZ UDS UPT VH1 VVN W8F WH7 WOQ X7H X7M XJT Y6R YAYTL YHZ YKOAZ YQT YR5 YXANX ZKX ZRR ZY1 ~91 ~H1 ~X8 7X8 |
| ID | FETCH-LOGICAL-c326t-750f9d00e24e34d572dc9e0f1bac8092f0551479ea191fa2947d6d65afd954112 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 424 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000375404600016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1460-2105 |
| IngestDate | Wed Oct 01 13:46:26 EDT 2025 Mon Jul 21 05:57:10 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c326t-750f9d00e24e34d572dc9e0f1bac8092f0551479ea191fa2947d6d65afd954112 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://academic.oup.com/jnci/article-pdf/108/5/djv370/7678956/djv370.pdf |
| PMID | 26657334 |
| PQID | 1749995974 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1749995974 pubmed_primary_26657334 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-May 20160501 |
| PublicationDateYYYYMMDD | 2016-05-01 |
| PublicationDate_xml | – month: 05 year: 2016 text: 2016-May |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JNCI : Journal of the National Cancer Institute |
| PublicationTitleAlternate | J Natl Cancer Inst |
| PublicationYear | 2016 |
| References | 26657336 - J Natl Cancer Inst. 2016 May;108(5). pii: djv410. doi: 10.1093/jnci/djv410 |
| References_xml | – reference: 26657336 - J Natl Cancer Inst. 2016 May;108(5). pii: djv410. doi: 10.1093/jnci/djv410 |
| SSID | ssj0000924 |
| Score | 2.6484115 |
| Snippet | Evidence suggests that a considerably large proportion of cancer patients are affected by treatment-related financial harm. As medical debt grows for some with... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| SubjectTerms | Communication Cost-Benefit Analysis Health Care Costs - trends Health Expenditures - trends Health Literacy Humans Insurance Coverage Insurance, Health Medicare Neoplasms - economics Neoplasms - mortality Neoplasms - therapy Quality of Life Stress, Psychological - etiology United States - epidemiology |
| Title | Financial Toxicity of Cancer Care: It's Time to Intervene |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26657334 https://www.proquest.com/docview/1749995974 |
| Volume | 108 |
| WOSCitedRecordID | wos000375404600016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07a8MwEBZtU0qXvh_pCxUKnUQcS7asLqWEhmZIyJBCNiPrAclgp7Eb2n_fk62QqVDo4sFYYE6nu-90jw-hB0YzDW4yI0bymLBMJUSKREKUYmjCAScZyWqyCT4aJdOpGPsLt9KXVa5tYm2odaHcHXkHkLNws7E4e158EMca5bKrnkJjG7UoQBmn1Xy6mRYeiIbUlsUBgdAm8v15EMR35rmadfR8RXnwO7asfUz_8L9_d4QOPLrEL406HKMtk5-gvaHPn58i0V8P2MCT4gteVt-4sLjntn6JXS_SEx5UjyV2nSG4KvDAl0SaM_Tef5303ognTyAKEFlFAAlYoYPAhMxQpiMeaiVMYLuZVAkIxgYOK3FhJERsVoaCcR3rOJJWi4gBCjtHO3mRm0uEY_hSOHpTTgVTUZbRSCilTWzBuVvJ2uh-LZQUlNNlHGRuis8y3YiljS4ayaaLZopGGrqcD6Xs6g-rr9E-AJW4KTS8QS0LR9Pcol21qmbl8q7edXiOxsMf69e2Mw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Financial+Toxicity+of+Cancer+Care%3A+It%27s+Time+to+Intervene&rft.jtitle=JNCI+%3A+Journal+of+the+National+Cancer+Institute&rft.au=Zafar%2C+S+Yousuf&rft.date=2016-05-01&rft.issn=1460-2105&rft.eissn=1460-2105&rft.volume=108&rft.issue=5&rft_id=info:doi/10.1093%2Fjnci%2Fdjv370&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2105&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2105&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2105&client=summon |